The Bridge to Good Health Care

For Translation Purposes Only
June 2, 2014
Listed Company Name:
Representative:
Stock exchange listing:
Securities code:

JMS Co., Ltd.
Hiroaki Okukubo
President and Representative Director
Tokyo 1st section
7702

Notice regarding Establishment of New Company in the Philippines and Factory Building at
IZUMO plant for production capacity enhancement.
～ For global business expansion to meet growing global healthcare markets ～JMS Co., Ltd. (headquarters: Hiroshima, Japan; President: Hiroaki Okukubo; hereinafter: JMS) announces toestablish a new company in Republic of the Philippines and a new factory building at IZUMO plant, thedomestic mother plant for business expansion in Japan and overseas markets by enhancing production
capacity and cost competitiveness.
1. Background and Purpose
Recently, there are growing demands for safer, more reliable, and high quality medical products, especiallyin emerging countries based on the improvement of medical infrastructure and national income driven by
their strong economic growth. In Japan, the national healthcare expenditure is soaring likewise due to thegrowing demands driven by the aging society along with more advanced but expensive medical treatments.
Given this situation, the government is trying to curb the growth of total healthcare expenditure to deal withthe financial deficit and its healthcare budget. For this reason, it is increasingly important to provide themedical products which can support more cost-efficient medical services.
JMS Group has been providing medical products to patients and medical professionals in more than 80
countries from our production sites located in Japan and Asian countries. We have decided to establish a
new plant in the Philippines and additional factory building at our mother plant located in IZUMO to meetthese growing global demands for medical products as a source of our growth, and supply the products formore cost-effective medical service by enhancing our cost competitiveness. We will proceed withrestructuring of production sites utilizing their strength and capability to the maximum extent from theviewpoint of group-wide optimal production for global business expansion.
2. Overview of new company & building expansion【New Company】
1. Company name
2. Location
3. President
4. Capital
5. Business
6. Establishment
7. Capital Contribution ratio
8. Production Commencement
9. Site area

JMS HEALTHCARE PHL, INC.
First Philippine Industrial Park, Tanauan City, Batangas
Republic of the Philippines
Kazuo Maehara
212 million PHP (approx. 500 milion JPY)
Manufacturing and selling medical devices for Infusion/Transfusion
therapy and Hemodialysis treatment.
May 20th, 2014
100% owned by JMS
April 2016
47,600 ㎡ (Floor area: approx. 15,000 ㎡)

JMS CO.,LTD. PRESS RELEASE【New Factory Building】
1. Name2. Location
3. Floor area
4. Products
5. Production Commencement

JMS Co., Ltd. IZUMO plantShimokoshi-cho, Izumo, Shimane, Japan
10,724 ㎡
Related products of Pre-filled syringes and Cardiovascular therapy
End of 2015

JMS will care for patients, and provide safer, reliable, and high quality goods and services from the medical
professionals’ perspective to contribute to the medical and society based on our theme; ‘medical safety’,‘medical efficiency’, ‘regenerative medicine’ and ‘improving the quality of life (QOL) for people requiring
medical services’.

～ Contact ～Corporate Planning Dept.

E-Mail: pub-bpd@jms.cc

The forecast in this press release is based on limited information available at the moment of disclosure and containpotential risks and uncertainty such as changes in social conditions. It should be noted that this press release is basedon the information available as of disclosure, and may differ in the future.

<END>

- 2 -